SANTINI GINO

CIK 00012760388 companiesINDIANAPOLIS, IN

SEC Profile

Transactions

Companies

Filings

CIK

0001276038

Recent Transactions

50 trades

Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2025-08-15$13.45/sh+15,000→ 100,447 total
Exercise/Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Stock Option (Right to Purchase)
2025-08-15−15,000→ 0 total
Sale
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2025-08-15$37.19/sh−5,405→ 95,042 total
Award
COMPASS Pathways plc$CMPS
Share Option (Right to Buy)
2025-06-12+39,000→ 39,000 total
Award
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2025-05-15+9,791→ 85,447 total
Award
COMPASS Pathways plc$CMPS
Share Option (Right to Buy)
2024-09-03+52,000→ 52,000 total
Award
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2024-05-16+7,693→ 75,656 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−2,748→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−1,598→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−2,966→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−12,089→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−2,174→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−2,036→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−12,790→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-11-08$19.00/sh−8,111→ 0 total
Disposition from Tender
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-11-08$19.00/sh−23,645→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−12,547→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−3,500→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−4,016→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
2023-10-06−8,548→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
2023-10-06−32,161→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-10-06$116.50/sh−100,959→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-10-06$116.50/sh−18,655→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
2023-10-06−31,153→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-10-02$15.23/sh+23,092→ 100,959 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Stock Option (Right to buy)
2023-10-02−23,092→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-09-22$15.96/sh+20,000→ 77,867 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Stock Option (Right to buy)
2023-09-22−20,000→ 0 total
Award
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-07-27+4,016→ 4,016 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-05-24+8,111→ 31,756 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-05-24+12,547→ 12,547 total
Award
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2023-05-18+9,792→ 67,963 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-04-28−3,913→ 0 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-04-28+3,913→ 57,867 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2022-05-25+12,790→ 12,790 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2022-05-25+7,737→ 23,645 total
Award
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-05-19+14,035→ 58,171 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2022-04-29−4,223→ 0 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-04-29$98.56/sh−1,658→ 48,814 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2022-04-29+4,223→ 50,472 total
Award
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2022-04-28+3,913→ 3,913 total
Award
Allena Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-06-03+37,000→ 37,000 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2021-05-27+12,089→ 12,089 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-05-27+7,029→ 15,908 total
Award
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2021-05-20+9,941→ 44,136 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2021-04-30+11,098→ 50,606 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2021-04-30−11,098→ 0 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2021-04-30$94.62/sh−4,357→ 46,249 total
Award
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2021-04-29+4,223→ 4,223 total
Sale
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2021-03-01$91.47/sh−12,000→ 23,795 total

Companies

Recent Filings

Address

LILLY CORPORATE CENTER

INDIANAPOLIS, IN, 46285

View on SEC.gov